MediPharm Labs (MLZ) Financial Statements
MediPharm Labs Financial Overview
MediPharm Labs's market cap is currently $17.73M. The company's EPS TTM is $-0.01; its P/E ratio is -5.60; MediPharm Labs is estimated to report earnings on November 16, 2026, and the estimated EPS forecast is $-0.00. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Mar 25 | Dec 23 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 45.12M | $ 41.96M | $ 33.06M | $ 22.12M | $ 21.71M |
| Gross Profit | $ 13.97M | $ 12.80M | $ 5.86M | $ -1.91M | $ -15.25M |
| Operating Income | $ -8.41M | $ -10.81M | $ -18.25M | $ -29.53M | $ -48.92M |
| EBITDA | $ -6.54M | $ -7.52M | $ -10.48M | $ -27.09M | $ -38.55M |
| Net Income | $ -8.27M | $ -10.69M | $ -13.08M | $ -29.98M | $ -54.80M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 10.81M | $ 11.69M | $ 17.98M | $ 24.14M | $ 34.11M |
| Total Assets | $ 45.74M | $ 53.73M | $ 63.94M | $ 65.50M | $ 92.36M |
| Total Debt | $ 201.00K | $ 388.00K | $ 2.29M | $ 632.00K | $ 216.00K |
| Net Debt | $ -10.61M | $ -11.30M | $ -15.69M | $ -23.51M | $ -33.89M |
| Total Liabilities | $ 9.93M | $ 10.55M | $ 10.93M | $ 9.49M | $ 9.21M |
| Stockholders' Equity | $ 35.81M | $ 43.18M | $ 53.01M | $ 56.01M | $ 83.15M |
| Cash Flow | |||||
| Free Cash Flow | $ -5.60M | $ -5.01M | $ -12.81M | $ -16.93M | $ -14.00M |
| Operating Cash Flow | $ -5.50M | $ -4.86M | $ -12.34M | $ -16.07M | $ -13.21M |
| Investing Cash Flow | $ 4.62M | $ 413.00K | $ 6.87M | $ 5.16M | $ 35.00K |
| Financing Cash Flow | $ -18.00K | $ -1.85M | $ -368.00K | $ 796.00K | $ 27.80M |
Currency in CAD